Breckenridge Ferrex 150 Capsules - 100 CAP

Breckenridge Ferrex 150 Capsules - 100 CAP
  • S3 image

Breckenridge Ferrex 150 Capsules - 100 CAP

  • SKU: 851429588
  • UPC: 35199120311
  • Size: 100 CAP
  • Manufacturer: BRECKENRIDGE PHARM INC

We will notify you when the product will be on sale

This item is out of stock.

Sign up to get notified when it becomes available

Quantity

We will notify you when the product will be on sale

This item is out of stock.

Sign up to get notified when it becomes available

Quantity

This product may be used for the dietary management of iron deficiencies. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Usual adult dosage is one or two capsules daily or as directed by a physician or health care provider. Do not exceed recommended dosage. Store at 25 degrees C (77 degrees F); excursions permitted to 15-30 degrees C (59-86 degrees F). Protect from light and moisture.

1 Capsule: Iron (Elemental) (as Polysaccharide-Iron) 150 mg; Sodium Lauryl Sulfate; Gelatin; Microcrystalline Cellulose; Stearic Acid; Polyethylene Glycol; Citric Acid; Croscarmellose Sodium; Titanium Dioxide; Polyvinylpyrrolidone; FD&C Yellow No. 5 Lake (Tartrazine, as a Color Additive); FD&C Red No. 40 Lake; FD&C Red No. 3 Lake; FD&C Blue No. 1 Lake

CONTRAINDICATIONS: Ferrex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications in the use of this dietary supplement. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons). Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity. The type of anemia and the underlying cause or causes should be determined before initiating supplementation with Ferrex 150. Since the anemia may be a result of a systematic disturbance, such as a recurrent blood loss, the underlying cause or causes should be corrected if possible. As with all oral iron preparations, Ferrex 150 should be stored out of the reach of children to protect against accidental iron poisoning. Patients should not exceed the recommended dosage unless directed by a physician. Patients should be informed that iron products can cause dark or black stools. Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other. If pregnant, or planning to become pregnant or are currently breast-feeding, please contact your physician or health-care provider before using or continuing use. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. ADVERSE REACTIONS: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stool and abdominal pain. Adverse reactions with iron therapy are usually transient. OVERDOSE: The clinical cause of acute iron overdose can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma. To report a serious adverse event contact 1-800-367-3395